San Diego, CA – According to filings with the U.S. Securities and Exchange Commission, Provisio Medical is raising $4,000,002.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Eric Ryan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Provisio Medical
Provisio Medical, Inc. is a development-stage medical device company dedicated to developing a market disrupting technology that is compatible with multiple interventional devices, to enable revolutionary improvements in vascular and cardiovascular healthcare. Sonic Lumen Tomography is a novel intravascular ultrasound technology (SLT IVUS) that provides accurate and precise real-time flow lumen dimensions. The SLT IVUS platform may also be easily integrated into many of the endovascular devices that physicians are already using today. Without the shortcomings of angiography’s ionizing radiation and kidney-toxic contrast media, Provisio’s SLT IVUS platform looks to seamlessly provide physicians the exact information that they need, when they need it, to improve both clinical workflows and outcomes. Provisio is creating a new paradigm in intravascular measurements to assess clinical presentation, guide treatment decisions such as proper sizing of therapeutic endovascular devices and confirm completion of treatment therapies.

To learn more about Provisio Medical, visit http://www.provisiomed.com/

Contact:
Eric Ryan, President and Chief Executive Officer
858-524-3901
https://www.linkedin.com/in/s-eric-ryan-m-d-619ba335/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved